ferric ammonium citrate

Trade name: Ferriseltz

Small moleculeapproved

Approved

Oct 14, 1997

Ammonium ferric citrate has the formula [NH4]y[Fex(C6H4O7)]. The iron in this compound is trivalent. All three carboxyl groups and the central hydroxyl group of citric acid are deprotonated. A distinguishing feature of this compound is that it is very soluble in water, in contrast to ferric citrate which is not very soluble. — Wikipedia

Clinical trial activity

2 trials · 3 clinical orgs · 1 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1

Earliest trial started Feb 1, 2019 (NCT03836703)

Timeline

1990s

  1. Oct 14, 1997

    Otsuka — Earliest FDA Approval

  2. Oct 14, 1997

    Otsuka — NDA Secondary Org

  3. Oct 14, 1997

    Otsuka — NDA Organization

Indications

Mechanism of action

Approval history

  • approvedOct 14, 1997

Chemistry & pharmacology

Mol. weight
261.98 g/mol
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Delivery
Oral
Availability
Discontinued

Oral

Yes

Parenteral

No

Topical

No

Sources

Also known as

  • ammonium ferric citrate
  • ammonium ferric citrate
  • ferric ammonium citrate
  • ferric ammonium citrate
  • ferric ammonium citrate
  • ferric ammonium citrate
  • ferriseltz
  • ferriseltz
  • ferriseltz

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04721964N/AFeb 25, 2021Jomo Kenyatta University of Agriculture and Technology, Swiss Federal Institute of Technology
NCT03836703Phase 4Feb 1, 2019Ain Shams University
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Ain Shams UniversityAcademic/Hospital1112019
Jomo Kenyatta University of Agriculture and TechnologyAcademic/Hospital1012021
Swiss Federal Institute of TechnologyAcademic/Hospital1112021
3 organizations
Page 1 / 1

Marketing (2)

OrganizationOrg typeRelationshipDate
OtsukaFor profitNDA2Oct 14, 1997
OtsukaFor profitNDAOct 14, 1997